Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge
How it worksResultsPricingMeet StoptieThe AlgoBlog
Sign InStart Free Trial
Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge

Algorithmic scanning across the S&P 500 & Nasdaq 100. Stock & Options trade cards in your inbox by 9:45 AM ET every trading day.

Product
  • How it works
  • The Algorithm
  • Ticker Setups
  • Pricing
  • Morning Brief
  • Results
  • Compare tools
Account
  • Sign In
  • Start Free Trial
  • Give a gift
  • Dashboard
  • Settings
Company
  • About
  • Contact
  • Partners
  • Support
  • Blog
  • Sitemap
Legal
  • Terms of service
  • Privacy policy
  • Risk disclosure
  • Unsubscribe

© 2026 Stoptions.ai · All Rights Reserved

Not financial advice. Algo-generated setups are not personalised investment advice. Options trading involves significant risk of loss — past performance does not guarantee future results.

Chat with Stoptie
Stoptions.ai›Tickers›Health Care›COR
Health Care

CORHealth Care sectorStock and Options Trade Setup — Cencora Inc.

COR logoNYSE · S&P 500 · Pharmaceutical Distribution & Services · Moderate liquidity options · Large cap · ~$52B

Last updated: Tuesday, August 11, 2026 · 9:31 AM ET
↻ Next update: Thursday, August 20, 2026 · 9:31 AM ET
▼ Bullish setupHealthcareDistributionDefensiveLow risk↑ Score -1 vs last update
81
Amora Edge Score
81
Top 10%
↓ -1 vs last update
Composite of EMA, RSI, RS vs SPY & volume · updated every 72h
0%
COR Win Rate
0%
0 of 2 COR setups resolved as WIN in 2026
Tracks completed Stoptions setups on this ticker since Jan 2026
-24.8%
COR Avg Return
-24.8%
Blended avg return across all 2 closed setups (wins & losses)
Blended avg return per closed setup (wins & losses) in 2026
Why we cover COR

Pharmaceutical distribution is an oligopolistic, volume-driven business with near-indestructible economics: Cencora, McKesson, and Cardinal Health collectively control ~90% of U.S. drug distribution. Switching costs are prohibitive, contracts are multi-year, and the fee-for-service model means Cencora benefits from rising drug prices without bearing drug pricing risk. The specialty pharma segment — oncology, immunology, rare disease — is growing faster than generics and carries higher margins. GLP-1 drug distribution volumes are adding a new high-growth layer as semaglutide adoption accelerates across the U.S. Cencora is also expanding internationally through its Alliance Healthcare operations in Europe. Free cash flow generation is exceptional, and the company has returned $2B+ annually to shareholders via buybacks and dividends. In any economic environment, people take their medications — making this a true recession-proof business.

Real Results

Last 2 COR Setups — Logged & Resolved

The most recent setups the scanner delivered for COR — logged at delivery, resolved when stop or target was hit.

Aug 7
stocks
Conviction
86
Entry
$324.49
Exit
$316.70
Days Held
5
Return
-2.4%
Stopped Out
Aug 13
options
Conviction
16
Entry
$23.70
Exit
$313.87
Days Held
0
Return
-47.3%
Stopped Out

Score History & Signal Changelog

● Live data

This page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.

Score progression · last 3 scans (~9 days)
Solid = composite · dashed = components
Signal Changelog
DateUpdateScoreDeltaKey change
Aug 6Score update81+0Score holding steady
Aug 7Score update82+1Score improving — signals strengthening
Aug 11Score update81-1Minor pullback — watching signals

Signal Breakdown

EMA Cross
Holding
24/25
RSI Zone
Holding
20/25
RS vs SPY
Holding
20/25
Volume Surge
Holding
16/25

Today's Trade Card

Setup
COR $290 CALL
Expires Jun 20, 2026
Premium
$6.80
Target
+70% premium
Stop loss
-50% premium
Breakeven
$296.8
Win prob.
40%
Sizing: Risk ≤ 1% of account
Greeks
Delta
0.36
Theta
-0.14
IVR
24%
IVR class
Low
Loading…

Options Profile

Avg IV (30d)
18%
IVR range (52-wk)
12–38%
Put/call ratio
0.62
Avg daily vol.
3.4K contracts
Open interest
52K contracts
Next earnings
Aug 7, 2026 (est.)

Risks & Fundamentals

Every setup carries risk. Here's what could move COR against you, plus the key stats that frame any position.

Beta
0.5
Market cap
~$52B
Risk level
Low risk
Next earnings
Aug 7, 2026 (est.)
Key risks to monitor
  • 1.Drug pricing reform legislation could restructure distributor economics if passed
  • 2.Opioid settlement liabilities — though substantially reserved — remain a tail risk
  • 3.Generic drug pricing deflation compresses volume-based margin contribution
These are real risks to the long thesis, not a recommendation to short. Stoptions setups are short-dated and stop-protected; size accordingly.

COR Options Setup — Frequently Asked Questions

Is COR a good options trade today?+

Cencora Inc. (COR) currently has an Amora Edge Score of 81/100, ranking it top 10%. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned cautious (smaller size or wait for confirmation). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.

What is COR's win rate on Stoptions.ai setups?+

COR's historical win rate on closed Stoptions setups is 0%. Win rate is calculated as the percentage of past COR trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.

What strike and expiry does Stoptions.ai suggest for COR?+

The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.

How often is the COR setup updated?+

Every 72 hours we refresh COR's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If COR drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.

What does the Amora Edge Score measure for COR?+

The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to COR: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is COR outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. COR currently scores 81.

How does COR compare to other Pharmaceutical Distribution & Services setups?+

COR's sector rank and percentile against other Pharmaceutical Distribution & Services tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Pharmaceutical Distribution & Services Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.

Educational content only — not personalized investment advice. Options carry substantial risk.

The Weekly · Free

Get a Friday Recap Including Setups Like COR.

Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.

No spam. One email Friday afternoon. Unsubscribe in one click.

More from Stoptions.ai
← All tickersBrowse by sectorHow the algorithm worksMorning BriefResultsPricing